Abstract
The influence of a fat-rich meal on the pharmacokinetics of cyclosporine from a new oral formulation (Sandimmune Neoral) was compared in a randomized, four-way crossover study to the currently marketed formulation (Sandimmune) in 24 healthy male volunteers. Single oral doses of 300 mg Sandimmune and 180 mg Sandimmune Neoral were each administered once under fasting conditions and once 30 min after starting a high-fat meal. Serial blood samples were obtained over a 48-hr period after each administration, and whole-blood cyclosporine concentrations were determined by a specific monoclonal radioimmunoassay method. Food had a marked effect on cyclosporine absorption from Sandimmune manifested by a nearly doubled time to reach the peak concentration and a 37% increase in the area under the curve. This was associated with significant elevations in subsequent whole-blood cyclosporine concentrations compared to the fasting administration. For Sandimmune Neoral the influence was less pronounced. The maximum concentration was decreased by 26%, without a relevant change in the time to reach the peak; the area under the curve showed a slight reduction of 15%. The relatively minor influence of a fat-rich meal on the absorption of cyclosporine from Sandimmune Neoral is advantageous when individualizing a dosage regimen under clinical and out-patient administration conditions.
Similar content being viewed by others
REFERENCES
R. J. Ptachcinski, R. Venkataramanan, and G. J. Burckart. Clinical pharmacokinetics of cyclosporin. Clin. Pharmacokinet. 11:107–132 (1986).
P. A. Keown, C. R. Stiller, N. R. Sinclair, G. Carruthers, W. Howson, M. Stawecki, J. McMichael, J. Koegler, N. McKenzie, and W. Wall. The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay. Transplant. Proc. 15:2438–2441 (1983).
A. Lindholm, S. Henricsson, and R. Dahlqvist. The effect of food and bile acid administration on the relative bioavailability of cyclosporin. Br. J. Clin. Pharmacol. 29:541–548 (1990).
N. Honcharik, R. W. Yatscoff, J. R. Jeffery, and D. N. Rush. The effect of meal composition on cyclosporine absorption. Transplantation 52:1087–1089 (1991).
R. J. Ptachcinski, R. Venkataramanan, J. T. Rosenthal, G. J. Burckart, R. J. Taylor, and T. R. Hakala. The effect of food on cyclosporine absorption. Transplantation 40:174–176 (1985).
S. K. Gupta, R. C. Manfro, S. J. Tomlanovich, J. G. Gambertoglio, M. R. Garovoy, and L. Z. Benet. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration. J. Clin. Pharmacol. 30:643–653 (1990).
P. E. Ball, H. Munzer, H. P. Keller, E. Abisch, and J. Rosenthaler. Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. Clin. Chem. 34:257–260 (1988).
J. Grevel, E. Nüesch, E. Abisch, and K. Kutz. Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects. Eur. J. Clin. Pharmacol. 31:211–216 (1986).
J. P. Reymond, J. L. Steimer, and W. Niederberger. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers. J. Pharmacokinet. Biopharm. 16:331–353 (1989).
PCNONLIN (Version 3.0), SCI Software, Statistical Consultants, Lexington KY, 1989.
RS/1 for VAX and Micro VAX. Release 4 software, Bolt Beranek and Newman (BBN) Software Products Corp., Cambridge, MA, 1988.
V. W. Steinijans, M. Hartman, R. Huber, and H. W. Radtke. Lack of pharmacokinetic interaction as an equivalence problem. Int. J. Clin. Pharmacol. Ther. Toxicol. 29:323–328 (1991).
D. Hauschke, V. W. Steinijans, and E. Diletti. A distribution-free procedure for the statistical analysis of bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 28:72–80 (1990).
S. K. Gupta and L. Z. Benet. High-fat meals increase the clearance of cyclosporine. Pharm. Res. 7:46–48 (1990).
P. G. Welling. Influence of food and diet on gastrointestinal drug absorption. J. Pharmacokinet. Biopharm. 5:291–334 (1977).
W. M. Awni, B. L. Kasiske, K. Heim-Duthoy, and K. Venkateswara. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: Effects of binding and metabolism. Clin. Pharmacol. Ther. 45:41–48 (1989).
J. Reymond, H. Sucker, and J. Vonderscher. In vivo model for ciclosporin intestinal absorption in lipid vehicles. Pharm. Res. 5:677–679 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mueller, E.A., Kovarik, J.M., van Bree, J.B. et al. Influence of a Fat-Rich Meal on the Pharmacokinetics of a New Oral Formulation of Cyclosporine in a Crossover Comparison with the Market Formulation. Pharm Res 11, 151–155 (1994). https://doi.org/10.1023/A:1018922517162
Issue Date:
DOI: https://doi.org/10.1023/A:1018922517162